Skip to content

PRV-based Detection of CAD in Comparison to Standard Methods

Comparison of a Pulse Wave Based Approach for Detection of Coronary Artery Disease Compared to Standard Methods

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02404948
Acronym
PRV-KORO
Enrollment
156
Registered
2015-04-01
Start date
2015-04-30
Completion date
2017-06-30
Last updated
2018-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

coronary artery disease, diagnosis, non-invasive

Brief summary

This is a validation study comparing a pulse wave based algorithm for the detection of coronary artery disease with parameters from coronary angiography, echocardiography and cardiogoniometry.

Detailed description

The study will validate a pulse wave based algorithm for the detection of coronary artery disease (CAD) with parameters from standard methods. Subjects will be patients admitted to coronary angiography due to suspected CAD. Pulse wave signals will be analyzed according to novelly established algorithm regarding the presence of CAD and/or myocardial ischemia. These results be compared to the diagnoses made by coronary angiography (primary endpoint): presence of minimum one coronary artery stenose \>=50%. For secondary analyses, results will be compared to parameters form echocardiography and cardiogoniometry.

Interventions

Validation of a diagnostic algorithm used to detect coronary artery disease and/or myocardial ischemia based on pulse wave analyses.

Sponsors

University Medicine Greifswald
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Coronary angiography indication present * informed written consent

Exclusion criteria

* Previous coronary angiography * Known CAD (history of coronary angioplasty, stent implantation and/or bypass surgery) * atrial fibrillation (at time of measurement) * severe ventricular extrasystole (e.g. \>=10% ventricular extrasystoles, bigemina) * pregnancy, lactation

Design outcomes

Primary

MeasureTime frameDescription
Presence of CAD - angio (minimum 1 stenosis >=50%)1 dayPresence of CAD in coronary angiography: minimum 1 stenosis \>=50%

Secondary

MeasureTime frameDescription
Presence of CAD number - angio (Number of coronary vessels with at least 1 stenosis >=50% in coronary angiography)1 dayNumber of coronary vessels with at least 1 stenosis \>=50% in coronary angiography
Wall motion abnormality - echo (Presence of wall motion abnormality in at least 1 segment (2D echocardiography)1 dayPresence of wall motion abnormality in at least 1 segment (2D echocardiography)
Wall motion index - echo (Wall motion index (2D and 3D echocardiography)1 dayWall motion index (2D and 3D echocardiography)
Global longitudinal strain (2D and 3D echocardiography)1 dayGlobal longitudinal strain (2D and 3D echocardiography)
Abnormal cardiogoniometry1 dayAbnormal results of cardiogoniometry

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026